TABLE 3.

Cell apoptosis analyses (%), as shown in Figure 4, after bortezomib treatment.

Bortezomib	GIST48B						GIST54							GIST226
(nM)	Q1	Q2	Q3	Q4		Q1		Q2	Q3	Q4			Q1		Q2	Q3	Q4
DMSO	0.011	3.07	0.12	96.8		0.06		5.61	0.54	93.8			0		4.04	0.80	95.2
25	0.049	7.30	0.82	91.8		0.22		28.5	9.98	61.3			0.17		13.4	10.9	75.6
100	0.15	18.2	2.11	79.6		0.54		27.3	10.1	62.1			0.47		10.9	8.98	79.6